Ishita Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE806D01016
  • NSEID:
  • BSEID: 524400
INR
72.44
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 38

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ishita Drugs & Industries Ltd stock-summary
stock-summary
Ishita Drugs & Industries Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr.
Company Coordinates stock-summary
Company Details
Survey No 179/1 Taluka Sanand, Village Vasna-Iyava Ahmedabad Gujarat : 382170
stock-summary
Tel:
stock-summary
ishitadrugs@vsnl.net
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Umang Financial Services Limited (9.94%)

Highest Public shareholder

Mahendra Girdharilal Wadhwani (2.15%)

Individual Investors Holdings

46.63%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Jagdish Agrawal
Managing Director
51.0 lacs
Govind Gupta
Director
0
Abha Agrawal
Non Executive Director
0
Niranjan Agrawal
Director
0
Arvind Sapkal
Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Bulk Drugs
6.84
100.00%
 
100
Bulk Drugs
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 22 Cr (Micro Cap)

stock-summary
P/E

22.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

8.99%

stock-summary
Price to Book

2.00